These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

408 related items for PubMed ID: 22903530

  • 1. Tumor necrosis factor-α (TNF-α) stimulates the epithelial-mesenchymal transition regulator Snail in cholangiocarcinoma.
    Techasen A, Namwat N, Loilome W, Bungkanjana P, Khuntikeo N, Puapairoj A, Jearanaikoon P, Saya H, Yongvanit P.
    Med Oncol; 2012 Dec; 29(5):3083-91. PubMed ID: 22903530
    [Abstract] [Full Text] [Related]

  • 2. BMP-7 blocks the effects of TGF-β-induced EMT in cholangiocarcinoma.
    Duangkumpha K, Techasen A, Loilome W, Namwat N, Thanan R, Khuntikeo N, Yongvanit P.
    Tumour Biol; 2014 Oct; 35(10):9667-76. PubMed ID: 24969562
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Prognostic significance of snail expression in hilar cholangiocarcinoma.
    Kong D, Liang J, Li R, Liu S, Wang J, Zhang K, Chen D.
    Braz J Med Biol Res; 2012 Jul; 45(7):617-24. PubMed ID: 22570087
    [Abstract] [Full Text] [Related]

  • 5. Loss of E-cadherin promotes migration and invasion of cholangiocarcinoma cells and serves as a potential marker of metastasis.
    Techasen A, Loilome W, Namwat N, Khuntikeo N, Puapairoj A, Jearanaikoon P, Saya H, Yongvanit P.
    Tumour Biol; 2014 Sep; 35(9):8645-52. PubMed ID: 24867095
    [Abstract] [Full Text] [Related]

  • 6. EGF/EGFR axis contributes to the progression of cholangiocarcinoma through the induction of an epithelial-mesenchymal transition.
    Clapéron A, Mergey M, Nguyen Ho-Bouldoires TH, Vignjevic D, Wendum D, Chrétien Y, Merabtene F, Frazao A, Paradis V, Housset C, Guedj N, Fouassier L.
    J Hepatol; 2014 Aug; 61(2):325-32. PubMed ID: 24704591
    [Abstract] [Full Text] [Related]

  • 7. Prognostic significance of epithelial-mesenchymal transition-related markers in extrahepatic cholangiocarcinoma: comprehensive immunohistochemical study using a tissue microarray.
    Nitta T, Mitsuhashi T, Hatanaka Y, Miyamoto M, Oba K, Tsuchikawa T, Suzuki Y, Hatanaka KC, Hirano S, Matsuno Y.
    Br J Cancer; 2014 Sep 23; 111(7):1363-72. PubMed ID: 25077440
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Expression of Smad7 in cholangiocarcinoma: prognostic significance and implications for tumor metastasis.
    Huang Q, Liu L, Liu CH, Shao F, Xie F, Zhang CH, Hu SY.
    Asian Pac J Cancer Prev; 2012 Sep 23; 13(10):5161-5. PubMed ID: 23244128
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Angiotensin II enhances epithelial-to-mesenchymal transition through the interaction between activated hepatic stellate cells and the stromal cell-derived factor-1/CXCR4 axis in intrahepatic cholangiocarcinoma.
    Okamoto K, Tajima H, Nakanuma S, Sakai S, Makino I, Kinoshita J, Hayashi H, Nakamura K, Oyama K, Nakagawara H, Fujita H, Takamura H, Ninomiya I, Kitagawa H, Fushida S, Fujimura T, Harada S, Wakayama T, Iseki S, Ohta T.
    Int J Oncol; 2012 Aug 23; 41(2):573-82. PubMed ID: 22664794
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. MicroRNA-494-dependent WDHDI inhibition suppresses epithelial-mesenchymal transition, tumor growth and metastasis in cholangiocarcinoma.
    Liu B, Hu Y, Qin L, Peng XB, Huang YX.
    Dig Liver Dis; 2019 Mar 23; 51(3):397-411. PubMed ID: 30314946
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Bile acids repress E-cadherin through the induction of Snail and increase cancer invasiveness in human hepatobiliary carcinoma.
    Fukase K, Ohtsuka H, Onogawa T, Oshio H, Ii T, Mutoh M, Katayose Y, Rikiyama T, Oikawa M, Motoi F, Egawa S, Abe T, Unno M.
    Cancer Sci; 2008 Sep 23; 99(9):1785-92. PubMed ID: 18691339
    [Abstract] [Full Text] [Related]

  • 20. Long non-coding RNA NNT-AS1 promotes cholangiocarcinoma cells proliferation and epithelial-to-mesenchymal transition through down-regulating miR-203.
    Gu Y, Zhu Z, Pei H, Xu D, Jiang Y, Zhang L, Xiao L.
    Aging (Albany NY); 2020 Feb 05; 12(3):2333-2346. PubMed ID: 32019904
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.